'A second set of eyes': AI-supported breast cancer screening spots more cancers earlier, landmark trial finds
livescience.com
February 9, 2026
7 min read
🔥🔥🔥🔥🔥
39/100
Summary
AI-assisted mammography has been shown to detect more cases of breast cancer earlier and reduce missed diagnoses, according to a clinical trial. This technology acts as an additional layer of analysis in breast cancer screening.
Key Takeaways
- AI-assisted mammography has been shown to detect more cases of aggressive breast cancer and reduce missed diagnoses in a landmark clinical trial.
- The Mammography Screening with Artificial Intelligence (MASAI) trial demonstrated that AI can improve screening performance and reduce the workload of radiologists.
- This trial is the first to provide evidence that AI can improve patient outcomes in breast cancer diagnosis.
- Regular screening has significantly reduced late-stage cancer incidence, but some cancers remain undetected, particularly those that develop rapidly or are obscured by dense breast tissue.
